Thoracic Paravertebral Block, Erector Spinae Plane Block, and in Combined Paravertebral-erector Spinae Block
Pain, Postoperative, Thoracic Surgery, Video-Assisted, Thoracic Paravertebral Block
About this trial
This is an interventional treatment trial for Pain, Postoperative focused on measuring Erector spinae block, Thoracic paravertebral block, VATS
Eligibility Criteria
Inclusion Criteria:
- 18 to 80 years old
- ASA physical status I-II-III
- BMI 18 to 30 kg/m2
- Elective video assisted thoracoscopic surgery
Exclusion Criteria:
- Patient refusing the procedure
- Emergency surgery
- Chronic opioid or analgesic use
Sites / Locations
- Ankara Atatürk Chest Disease and Chest Surgery Training and Research Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
Thoracic Paravertebral Block
Erector spinae block
Thoracic Paravertebral block and Erector spinae Block
In patients who are planned to have a thoracic paravertebral block, the needle will be advanced to the paravertebral area with ultrasound-guided in-plane technique. 20 ml of 0.25% bupivacaine will be injected into this area.
Patients who are planned to have an erector spina block will be advanced to the interfacial area under the erector spinae muscle by ultrasound-guided in-plane technique. 20 ml of 0.25% bupivacaine will be injected into this area.
In patients who are planned to have combined erector spinae block and thoracic paravertebral block, the needle will be advanced to the paravertebral area with ultrasound-guided in-plane technique. 10 ml of 0.25% bupivacaine will be given to this area. Then, with the same needle, return 1-2 cm from the paravertebral area and inject 10 ml of 0.25% bupivacaine into the interfacial area under the erector spinae muscle.